A patient's self-reported wellbeing may better indicate their response to treatment than clinician-based data, new research has found.
The study from Flinders University compared nearly 3000 patients who were receiving therapy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer.
This type of cancer is associated with a poorer response to medication and has a four-year survival rate of just over 60 per cent.
Lead author and PhD candidate of the Clinical Cancer Epidemiology Lab, Natansh Modi, analysed whether a patient's estimate of their prognosis provided better insight into their response to treatment than a doctor's assessment.
"We found consistently across different types of cancers, and different subtypes of breast cancer as well, that the patient's report of their physical wellbeing is more predictive of their overall survival, and also of their progression-free survival as well," Modi says.
Currently, clinicians rely on the 'Eastern Cooperative Oncology Group performance status' (ECOG PS), which scores a patient's physical ability on a scale from one to four.
While it's been routinely used in oncology since the '80s, recent questions have been raised about whether it accurately reflects a patient's health.
"The problem with the ECOG tiers is that it's not standardised, so each clinician has their own way of interpreting the results," Modi says.
Interestingly, the study also found that in 70 per cent of cases, the clinician overestimated the patients' physical ability.
"Their clinicians defined as 'fully active, and able to carry on all pre-disease performance without restrictions' went on to report limitations in their physical wellbeing status when asked to self-report," says Modi.
"We found that the 'Patient-Reported Outcomes' (PROs) to be more reliable in predicting a patient's response to anticancer treatment and overall survival."
The PROs questionnaire is filled out by the patient on paper and includes open-ended questions about their quality of life.
Yet, PROs frequently retain a secondary role in clinical settings due to administrative challenges and clinicians' lack of time.
Here, Modi highlights the importance of nurses in conducting patient-reported questionnaires.
"Doctors go on rounds, but nurses are just looking after particular patients, and they're there when a patient needs something," Modi says.
"A lot of these activities with the questionnaires can be carried out by nurses because they spend the most time with patients compared to doctors, particularly in hospitals."
They also keep a close eye on the patient's response to anticancer treatment and their overall wellbeing, Modi says.
As patient-centred care has gained momentum in recent years, interest has grown in the use of PROs.
Patient-centred care is the process of shared decision-making between the clinician and patient to determine appropriate treatment and manage realistic expectations.
Modi says it's about providing a greater emphasis on the patient's perspective and their voice.
"I'm sure when people go to their doctors, you have a good inkling of what's wrong with you, right? You may not be completely correct, but you have some idea," Modi explains.
"Obviously, doctors know a lot about your body that you don't know, but it's also about incorporating what the patient thinks about their health."
While Modi emphasises the importance of PROs, he also underlines the benefit of ECOG tools.
"Clinicians look at data from ECOG tools as a primary outcome.
"But what I'm saying is: don't just look at ECOG – let's look at patient-reported outcomes as well and see how well patients are doing across that continuum."
Modi's Australian-first study connects the effectiveness of PROs in relation to predicting outcomes of treating (HER2)-positive breast cancer.
However, patient-reported questionnaires are already being implemented in countries such as Germany in digital formats.
"They have done successful clinical trials, where patients are given an app on their phone and report when they're experiencing a side effect from medication," Modi says.
"What this app does is that it gives you a reminder every morning and asks you, 'How did you feel yesterday after your medicine?'"
Modi says it effectively functions as a diary to keep track of side effects and a patient's wellbeing.
"Which then the clinician can look at and deceive whether to either increase the dose, lower the dose or just stop the medicine."
Modi is currently also working on creating such an app in Australia.
